Abstract

Highlights

  • No clear link between fluoride and primary bone cancers found in 12 of 14 studies.
  • Two studies report a positive link between fluoride and bone cancer in young males.
  • Most studies had low methodological quality, affecting reliability of findings.
  • No consistent links were observed across age, sex, or fluoride levels.
  • The review highlights the need for better-quality research on fluoride safety.

Fluoride has long been considered essential in the prevention of dental caries, however, its relationship with bone cancer remains unclear. With little improvements in survival from primary bone cancers, it is important to understand the underlying drivers. The focus of this systematic review was, therefore, to assess the association between fluoride exposure and the development of primary bone cancer. The review was conducted as per the PRISMA guidelines and was registered on PROSPERO (CRD42021296109) with a search cut-off of March 2024. In total, 14 studies, involving 8680 participants across all age groups, were identified examining the effects of fluoride exposure on humans investigated for primary bone cancer. Of the 14 studies, only two reported a positive association between fluoride and primary bone cancer. One study including 88 participants reported a positive association between water fluoridation and osteosarcoma development (in young males between 0 and 20 years of age), and the second study, with an unreported number of participants, reported this positive association with bone cancers in males. No association between fluoridation and bone cancer development was reported in the remaining studies. Across all 14 studies, data was presented in a narrative synthesis with subgroup analysis conducted on study design, age, sex, fluoride level and quality score. Both studies reporting a positive association between fluoride and bone cancer identified this association in males, however, both studies concluded that further research is needed. Here we report the most comprehensive systematic review to date examining associations between fluoride exposure and primary bone cancer. We also highlight some of the methodological limitations of some studies, and identify the need, and opportunity, to conduct a large, prospective study to address this and other health issues associated with fluoride.

Excerpts:

Introduction

Primary bone cancers are a group of aggressive malignant tumours arising in bone or cartilage, derived from primitive mesenchymal cells [1]. The most common malignant bone cancer subtypes include osteosarcoma (OS) accounting for 20–40% of all bone cancers, Ewing’s sarcoma (ES)<20% of all bone cancers, and Chondrosarcoma (CS) which varies ranging from <10% to >45% of all bone cancers, with <10% observed in India and Saudi Arabia, and >45% observed in Finland and Netherlands [2,3].

Few risk factors have been established but a predilection towards males has been identified on OS and ES [4]. Although some molecular characteristics have been studied, their mechanisms remain unclear [5], however, an increased risk in their development has been linked to certain heritable syndromes, such as Paget’s disease, Li-Fraumeni syndrome, and heritable retinoblastoma [6]. In addition, ionizing radiation exposure from prior cancer treatment, and exposure to environmental chemicals such as phenoxyacetic acid and chlorophenols found in herbicides and wood treatments, have been identified as potential risk factors [7]. Whether fluoride exposure is associated with an increased risk of developing bone cancers remains inconclusive [8].

To date, two systematic reviews have been conducted, investigating the safety and efficacy of fluoridation, both of which included evaluations on the effect of fluoridation on osteosarcoma and bone cancer, reporting no clear evidence of potential adverse effects from fluoridation [9,10]. Neither review was able to formally aggregate the results of their analysis on the association of cancers and fluoridation due to the varying outcome measures used by the included studies, limiting the statistical power of the systematic reviews, with both studies concluding no clear association was apparent between water fluoridation and osteosarcoma incidence and mortality. Both studies evaluated the effects of fluoride on dental caries, dental fluorosis, bone fracture, cancer, and other negative effects. However, the McDonagh review only considered water fluoridation as an exposure, while the study by Yeung and team included fluoride from multiple sources such as milk, salt, and topical supplementation [9,10]. This systematic review will include studies that have investigated any source of fluoride where the participants were investigated for primary bone cancer.

Since the establishment of water fluoridation programs in 1964, various Community Water Fluoridation (CWF) strategies have become a cost-effective public health success in the prevention of dental caries, and are now widely employed as a method to regulate fluoride levels in public water supplies (PWS) [11]. The role of CWF strategies is to prevent the development of caries in children and adults, regardless of socioeconomic status [12]. This public health strategy has led to CWF being labelled as one of the 10 greatest health achievements of the 20th century [13]. A review of the economic evaluations of water fluoridation was carried out by Mariño and Zaror [14], confirming the success of CWF was a cost-effective strategy and an appropriate use of community resources. Due to the detrimental effect of excessive fluoride exposure, such as dental and skeletal fluorosis [15,16], water fluoridation levels within PWS should not exceed 1.5 mg/L, as recommended by the World Health Organization (WHO) [17].

Within the UK, many areas’ PWS naturally contain 1 mg/L of fluoride, and the government endorses artificial fluoridation programs for those that fall below this level [18], however, a study conducted by Blakey et al. [19] suggests that up to a third of areas within the UK are currently supplied with artificially fluoridated water are below 0.7 mg/L, which is considered the lower limit of the optimal range for dental health benefits. In 1990 the public interest in the effects of fluoridation were renewed by a sodium fluoride water dosing study carried out by the National Toxicology Program NTP [20]. The study found that of the 130 male rats given 100 mg/L and 175 mg/L of fluoride, 4 developed OS, suggesting an equivocal link between fluoride ingestion and OS development. However, prior to the report by NTP being finalised [20], a two-year carcinogenicity study of sodium fluoride in male rats was conducted by Maurer et al. [21] to determine if long-term exposure induced cancer. The study, which assessed male rats on low fluoride diets, supplements with either 4/10/25 mg/kg per day sodium fluoride found that although fluoride toxicity was evident in the teeth and bones, the incidence of cancer did not increase. The authors concluded that sodium fluoride does not have a carcinogenic effect, even when administered at doses much higher than those typically found in humans.

In 2006, the USA’s National Academies released a National Research Council (NRC) report at the request of the Environmental Protection Agency (EPA) to evaluate their maximum contaminant level goal (MCLG) and secondary maximum contaminant goal (SMCL) for fluoride in drinking water [22]. The report reviewed the pharmacokinetics, adverse organ effects, genotoxicity, and carcinogenicity of fluoride exposure. The committee concluded that the current MCLG of 4 mg/L should be lowered, citing that excessive fluoride causes dental fluorosis in children and may not protect against fractures. Furthermore, the committee found that existing literature could not definitively classify fluoride as carcinogenic or non-carcinogenic in humans, noting that recommendations for individual-based cancer studies from the NRC’s 1993 report have only been partially fulfilled. While the use of cancer registries to ascertain cases was considered a strength of the included studies, the committee identified ecological studies as a weakness due to potential biases and poor adjustment for covariates.

While the body of evidence identifying the negative effects that excessive fluoride exposure has on dental health and skeletal fluorosis is well-recognised [15,16], the link between fluoridation and bone cancer development remains inconclusive [10]. The most recent systematic review addressing this association was published over a decade ago, and, with new studies published investigating the link between fluoride and bone cancer, there is a need for an up-to-date systematic review of this specific topic. Therefore, the focus of this systematic review was to analyse the literature reporting the relationship between fluoride exposure, emanating from topical or systemic origins, and the potential risk for the development of primary bone cancers.

Section snippets

Materials and methods

The conduct and reporting of this systematic review were carried out in accordance with the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [23], the Synthesis without meta-analysis (SWiM) reporting guidelines [24,25], and registered in the international prospective register of systematic reviews, PROSPERO (CRD42021296109) https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021296109

Study selection

During the review process, three database searches were conducted. The initial search was conducted on January 21st 2021, and identified 896 records. The second search, conducted on February 6th, 2023, identified an additional 59 records, and the third, on March 6th 2024, a further 19. Backward chaining was conducted, leading to the identification of a further 9 studies (2 of which were additional duplicates). After deduplication (n=413), 560 records were screened by title and abstract per…

Discussion

Fluoride and its health benefits in preventing dental cavities are well documented, particularly for young children living in deprived areas. A recent survey issued by the UK government showed a substantial difference in the percentage of school-aged children with tooth decay in the northeast (16%) compared with the less deprived southwest (12%) [51], and plan to tackle this issue through expanding the water fluoridation in areas of the UK [52]. Although fluoridation is used to address dental

Conclusion

Here we report the most up-to-date and comprehensive systematic review investigating the association between fluoride and bone cancers. In summary, 85 % (12/14) of the studies included did not support a link between fluoride ingestion and the development of bone cancers. However, due to the low quality of the majority of the included studies and study limitations we have highlighted, these results should be interpreted with caution. With the continued debate that surrounds the use of fluoride…

References (57)

  • N.V. Balmant et al. Incidence and mortality of bone cancer among children, adolescents and young adults of Brazil. Clinics (2019)
  • V. Aran et al. Osteosarcoma, chondrosarcoma and Ewing sarcoma: clinical aspects, biomarker discovery and liquid biopsy. Crit. Rev. Oncol. Hematol. (2021)
  • K. Rickel et al. Molecular genetics of osteosarcoma. Bone (2017)
  • C.A. Stiller et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur. J. Cancer (2013)
  • C. Hayes et al. A case-control study of topical and supplemental fluoride use and osteosarcoma risk. J. Am. Dent. Assoc. (2021)
  • M. Levy et al. Fluoride in drinking water and osteosarcoma incidence rates in the continental United States among children and adolescents. Cancer Epidemiol. (2012)
  • S.M. McGuire et al. Is there a link between fluoridated water and osteosarcoma? Journal of the American Dental Association (1939) (1991)
  • P.C. Valery et al. Bone cancer incidence by morphological subtype: a global assessment. Cancer Causes Control (2015)
  • W.I. Wan-Ibrahim et al. Biomarkers for bone tumors: discovery from genomics and proteomics studies and their challenges. Mol. Med. (2015)
  • X. Xie et al. A comprehensive understanding of the genomic bone tumor landscape: a multicenter prospective study. Frontiers in Oncology (2022)
  • N.R. Johnston et al. Principles of fluoride toxicity and the cellular response: a review. Arch. Toxicol. (2020)
  • M. McDonagh et al. A Systematic Review of Public Water Fluoridation (2000)
  • C.A. Yeung. A systematic review of the efficacy and safety of fluoridation. Evid. Based Dent. (2008)
  • J. Mullen. History of water fluoridation. Br. Dent. J. (2005)
  • Z. Iheozor-Ejiofor et al. Water fluoridation for the prevention of dental caries. Cochrane Database Syst. Rev. (2015)
  • (CDC), C. f. D. C. a. P. Ten great public health achievements—United States, 1900–1999. MMWR Morb. Mortal. Wkly Rep. (1999)
  • R. Mariño et al. Economic evaluations in water-fluoridation: a scoping review BMC Oral Health (2020)
  • P. DenBesten et al. Chronic fluoride toxicity: dental fluorosis Monogr. Oral Sci. (2011)
  • S. Srivastava et al. Fluoride in drinking water and skeletal fluorosis: a review of the global Impact Current Environmental Health Reports (2020)
  • WHO. Guidelines for Drinking-water Quality, 4th Edition, Incorporating the 1st Addendum (2017)
  • GOV.UK. Department of Health and Social Care, Care, D.o.H. and Social Health and Care Bill: Water Fluoridation
  • K. Blakey et al. Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0-49-year-olds in Great Britain, 1980-2005 Int. J. Epidemiol. (2014)
  • NTP. NTP toxicology and carcinogenesis studies of sodium fluoride (CAS No. 7681-49-4)in F344/N rats and B6C3F1 mice (drinking water studies). Natl. Toxicol. Program Tech. Rep. Ser. (1990)
  • J.K. Maurer et al. Two-year carcinogenicity study of sodium fluoride in rats. JNCI J. Natl. Cancer Inst. (1990)
  • National Research Council, D. o. E et al. Fluoride in Drinking Water: A Scientific Review of EPA’s Standards (2007)
  • M.J. Page et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (2021)
  • M. Campbell et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ (2020)
  • J. Popay et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version. (2006)

There are more references available in the full text version of this article.

__________________________________________________________________________________

ABSTRACT ONLINE AT https://www.sciencedirect.com/science/article/abs/pii/S8756328224003090
___________________________________________________________________________